DTC Eligibility for OTCQX Trading in the U.S.

Investing News NetworkYour trusted source for investing success

Download our investor reports
Start Here GuidesOutlook Reports
Copyright 2023 © Dig Media Inc.

Your trusted source for investing success since 2007. Renowned for our market outlook reports and investing guides.

gene therapy

LATEST ARTICLES
NEW! 2023 Life Science Outlook Report.

NEW! 2023 Life Science Outlook Report.

cas9 kit

Start Here – Investing in Genetics

Genetics Investing

Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy

Genetics Investing

Spark Therapeutics Reports First Quarter 2018 Financial Results and Recent Business Progress

Biotech Investing

Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update

Genetics Investing

Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa

Genetics Investing

AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data

Pharmaceutical Investing

Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

Pharmaceutical Investing

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

MARKETS

Markets
TSX20024.63+352.38
TSXV609.08+3.07
DOW33762.76+701.19
S&P 5004282.37+61.35
NASD13240.77+139.78
ASX7145.10+34.30

COMMODITIES

Commodities
Gold1947.16-2.10
Silver23.56-0.01
Copper3.71-0.02
Palladium1713.170.00
Platinum1087.260.00
Oil72.69+0.95
Heating Oil2.38+0.02
Natural Gas2.21+0.03

DOWNLOAD FREE REPORTS

BROWSE COMPANIES BY SECTOR

loader